Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
851
Central Garden & Pet Co
CENT
$2.54B
| $18.8M | 0.02% |
654,000
+44,875
| +7% | +$1.21M |
2013 Q2
28 quarters
|
|
|
PGRE
852
DELISTED
Paramount Group
PGRE
| $18.8M | 0.02% |
2,439,933
-1,643,866
| -40% | -$13.9M |
2017 Q4
10 quarters
|
|
853
Aurinia Pharmaceuticals
AUPH
$2.22B
| $18.8M | 0.02% |
1,157,500
-281,300
| -20% | -$4.5M |
2019 Q1
5 quarters
|
|
854
Hecla Mining
HL
$11.5B
| $18.8M | 0.02% |
5,735,565
-9,624,847
| -63% | -$26.6M |
2018 Q3
7 quarters
|
|
855
Hudbay
HBM
$11.6B
| $18.7M | 0.02% |
6,172,729
-127,200
| -2% | -$319K |
2016 Q2
16 quarters
|
|
856
Natera
NTRA
$57.8B
| $18.7M | 0.02% |
374,600
+27,800
| +8% | +$1.12M |
2019 Q4
2 quarters
|
|
|
SCS
857
DELISTED
Steelcase
SCS
| $18.6M | 0.02% |
1,542,900
-253,700
| -14% | -$2.78M |
2017 Q2
12 quarters
|
|
|
BIG
858
DELISTED
Big Lots, Inc.
BIG
| $18.6M | 0.02% |
+443,000
| New | +$12.6M |
2020 Q2
0 quarters
|
|
859
United States Lime & Minerals
USLM
$3.11B
| $18.6M | 0.02% |
1,098,825
-19,000
| -2% | -$296K |
2013 Q2
28 quarters
|
|
860
iShares 20+ Year Treasury Bond ETF
TLT
$46.7B
| $18.5M | 0.02% |
112,900
+106,000
| +1,536% | +$17.5M |
2020 Q1
1 quarter
|
|
|
PRA
861
DELISTED
ProAssurance
PRA
| $18.5M | 0.02% |
1,277,600
+225,700
| +21% | +$3.87M |
2014 Q4
22 quarters
|
|
862
Cloudflare
NET
$129B
| $18.5M | 0.02% |
514,100
-282,400
| -35% | -$7.89M |
2020 Q1
1 quarter
|
|
863
Teledyne Technologies
TDY
$28.4B
| $18.4M | 0.02% |
59,300
-1,100
| -2% | -$362K |
2019 Q4
2 quarters
|
|
|
AY
864
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $18.4M | 0.02% |
633,455
+8,300
| +1% | +$209K |
2017 Q1
13 quarters
|
|
865
Flex
FLEX
$44.3B
| $18.4M | 0.02% |
+2,384,558
| New | +$17.2M |
2020 Q2
0 quarters
|
|
866
Omega Healthcare
OHI
$13.5B
| $18.4M | 0.02% |
618,176
-1,331,688
| -68% | -$39.4M |
2018 Q3
7 quarters
|
|
867
McCormick & Company Non-Voting
MKC
$12.1B
| $18.4M | 0.02% |
204,556
-1,138,942
| -85% | -$93.8M |
2020 Q1
1 quarter
|
|
|
ACH
868
Accendra Health
ACH
$32.9M
| $18.3M | 0.02% |
2,407,050
-624,450
| -21% | -$4.57M |
2019 Q1
5 quarters
|
|
869
Waters Corp
WAT
$42.6B
| $18.3M | 0.02% |
+101,600
| New | +$19.2M |
2020 Q2
0 quarters
|
|
|
BCOV
870
DELISTED
Brightcove, Inc.
BCOV
| $18.3M | 0.02% |
2,318,627
+123,076
| +6% | +$991K |
2015 Q1
21 quarters
|
|
871
State Street Energy Select Sector SPDR ETF
XLE
$41.3B
| $18.2M | 0.02% |
+964,200
| New | +$17.9M |
2020 Q2
0 quarters
|
|
872
TriCo Bancshares
TCBK
$1.64B
| $18.2M | 0.02% |
599,014
-54,600
| -8% | -$1.56M |
2013 Q2
28 quarters
|
|
|
AJRD
873
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $18.2M | 0.02% |
459,895
-399,600
| -46% | -$16.6M |
2015 Q1
21 quarters
|
|
874
Rollins
ROL
$15.4B
| $18.2M | 0.02% |
643,950
+135,750
| +27% | +$3.63M |
2019 Q4
2 quarters
|
|
875
WesBanco
WSBC
$3.51B
| $18.1M | 0.02% |
893,323
+5,425
| +0.6% | +$119K |
2013 Q2
28 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.